Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors
Conditions
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- OTHER: Discontinuing Bruton tyrosine kinase inhibitors (BTKi) therapy
Sponsor
UNC Lineberger Comprehensive Cancer Center